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be exacerbated by T deprivation in people (Almeida et al., 2004; 
Sunderland et  al., 2004) and male mice (Rosario et  al., 2006). 
Together, these ﬁ  ndings suggest that androgens may play a role in 
age-related, hippocampally-  inﬂ  uenced, cognitive behavior.
Typical aging is associated with a decline in steroid hormones 
and cognitive and affective responses, which may be inﬂ  uenced by 
the hippocampus (Rosario et al., 2009). For example, compared to 
healthy, middle-aged counterparts, aged men and women expe-
rience impaired performance in tasks measuring visuo-spatial 
function (Clark et al., 2006), have increased self-reported feelings 
of depression (Butler, 2006), and exhibit increased incidence of 
anxiety disorders (Delhez et al., 2003). This decline occurs con-
comitantly with a decline in endogenous steroid hormone levels, 
which may inﬂ  uence these processes (Janowsky et al., 2000; Beer 
et al., 2006; Janowsky, 2006a,b). Unlike women that experience a 
precipitous decline in ovarian steroids with menopause (Markou 
et al., 2004), men experience a more gradual, decade-by-decade 
decline in their primary gonadal steroids, T and its metabolites, 
with aging (1.0–1.2% per year; Janowsky, 2006a,b). Differences 
in endogenous T levels may alter cognitive and affective behav-
INTRODUCTION
The hippocampus may be a target of androgens during aging. 
Alzheimer’s Disease (AD), associated with profound loss of declara-
tive memory, medial temporal lobe/hippocampus degeneration, 
and extensive accumulation of β-amyloid, is the most common 
form of dementia in the elderly, and is more prevalent in women, 
as compared to men (Light, 1991; Howieson et al., 1993). The 
increased incidence, onset and severity of AD among women, 
compared to men, has largely focused on effects of estrogen dep-
rivation (Henderson et al., 1996; Tang et al., 1996; Kawas et al., 
1997). However, persons with AD (Pike and Savage, 2008), those 
with lesions of the hippocampus (Rosenbaum et al., 2007), and/or 
androgen deprivation (Freedland et al., 2009), can all experience 
impairments in the processes by which information is consolidated 
or shifted to permanent storage compared to healthy, middle-aged 
counterparts. Moreover, low testosterone (T) levels may be a risk 
factor for AD, as some men with AD have lower T levels prior to 
their diagnosis than do healthy men (Hogervorst et al., 2003; Moffat 
et al., 2004; Raber, 2004, 2008; Pike et al., 2008; Rosario and Pike, 
2008). Even normative, age-  associated increases in β- amyloid  can 
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due to ovariectomy or aging (Markowska and Savonenko, 2002; 
Foster et  al., 2003; Savonenko and Markowska, 2003; Daniel 
et al., 2006; Talboom et al., 2008; Walf et al., 2009). However, 
there are differences in male and female response to different sex 
hormones (Gibbs and Johnson, 2008), which suggest that males 
respond more effectively to T treatment. Additionally, other stud-
ies have shown that estrogen and T may inﬂ  uence different types 
of memory (Gibbs, 2005). Finally, a study looking at the effects 
of estrogen on a model of AD in mice revealed that estrogen was 
not effective at preventing against AD-induced behavioral deﬁ  cits 
(Hunter et al., 2004). Thus, T’s other routes of metabolism should 
be more closely examined to determine its effects and mechanisms 
to enhance cognitive performance.
T can also be reduced with the 5α-reductase enzyme to dihy-
drotesterone (DHT), which is subsequently converted by 3α-
hydroxy-steroid dehydrogenase (3α−HSD) to the nonaromatizable 
metabolite, 5α-androstane, 17α-diol (3α-diol). 3α-diol adminis-
tration, systemically or to the hippocampus of GDX rats, enhances 
cognitive performance in the inhibitory avoidance, place learning, 
and object recognition tasks, and decreases anxiety in the elevated 
plus maze and open ﬁ  eld tasks (Frye and Lacey, 2001; Frye et al., 
2001; Edinger and Frye, 2004, 2005, 2007; Edinger et al., 2004). 
Further, blocking T’s metabolism to 3α-diol with indomethacin 
decreases cognitive performance and increases anxiety behavior 
of gonadally-intact and/or DHT-replaced rats (Frye and Edinger, 
2004; Frye et al., 2004). Together, these ﬁ  ndings suggest that T’s 
beneﬁ  cial effects on cognitive performance and affective behavior 
may be due, in part, to its metabolism to 3α-diol in the hippoc-
ampus of young rodents.
The previous studies suggest that age-associated deﬁ  cits in 
hippocampally-inﬂ   uenced cognitive and affective behaviors 
may be due to a decline in endogenous T levels, and/or T’s fail-
ure to metabolize to 3α-diol. To determine the extent to which 
some age-related deﬁ  cits in such performance are due to T’s 
metabolites, the effects of age-related androgen decline, gona-
dectomy, and androgen replacement on cognitive (inhibitory 
avoidance, Morris water maze) and affective (defensive freezing, 
forced swim) behavior among young (4 months), middle-aged 
(13 months), and aged (24 months) male rats was examined. We 
hypothesized that, if aging alters steroid levels, which in turn 
alter cognitive performance and affective behavior, that aged 
and GDX rats would have decreased plasma and hippocampal 
androgen metabolite levels, and decreased performance in cog-
nitive and affective tasks. Furthermore, if differences in steroid 
metabolism mediate T’s beneﬁ  cial effects on cognitive perform-
ance and affective behavior, that androgen regimen that increased 
3α-diol levels in the hippocampus and plasma would enhance 
cognitive and affective performance. In Experiment 1, 4-, 13-, 
and 24-month-old rats were either left intact or GDX. GDX rats 
received either an empty capsule or one ﬁ  lled with T (T-replaced), 
designed to release a sustained amount of hormone over time and 
produce physiological levels of circulating T (Frye and Edinger, 
2004; Frye et al., 2004). Based upon the results of Experiment 1, 
Experiments 2 and 3 were done, both of which utilized androgen 
regimen that was given acutely before affective testing or imme-
diately after training in the inhibitory avoidance and water maze 
tasks to coincide with the period of memory consolidation. In 
ior. In support, T or anabolic steroid administration to healthy 
young men enhances verbal memory (O’Connor et  al., 2001; 
Cherrier et al., 2002) and self-reported measures of mood and well-
being (Cafri et al., 2006) compared to healthy young men with 
no exogenous androgens. Low endogenous T levels as a result of 
hypogonadism, (Howell and Shalet, 2001; Kaminetsky, 2005) or 
aging (Janowsky et al., 1994; Sternbach, 1998; Lund et al., 1999; 
Davis, 2001; Li et al., 2002; Seidman, 2003; Orengo et al., 2004; 
Janowsky, 2006a,b) can diminish cognitive and affective behav-
ior, compared to their like-aged counterparts. These deﬁ  cits can 
be reduced through T-  replacement to young (Howell and Shalet, 
2001; Kaminetsky, 2005) and aged (Alexander et al., 1983; Delhez 
et al., 2003; Janowsky, 2006a,b) men with low endogenous T levels. 
However, these results are not consistent across all studies (Haren 
et al., 2002, 2005; Delhez et al., 2003; Wolf, 2003). Although there 
is considerable heterogeneity in age-related cognitive and affective 
decline, these data suggest that decrements in some measures of 
cognitive and affective performance among men with low endog-
enous T levels can be reversed with T-replacement.
Animal models also illustrate T’s beneﬁ  cial effects on cogni-
tive and affective behavior (as reviewed in Galea et al., 2008). In 
 gonadally-intact rats, systemic T administration enhances cognitive 
performance in the object recognition (Ceccareli et al., 2001) task 
and decreases anxiety-like behavior in the elevated plus maze and 
Vogel punished drinking paradigm (Bitran et al., 1993; Bing et al., 
1998). Gonadectomy (GDX), or removal of the primary source 
of male androgens, the testes, decreases cognitive performance 
(Ceccareli et al., 2001; Frye and Seliga, 2001; Edinger and Frye, 
2004; Edinger et al., 2004; Kritzer et al., 2007; Aubele et al., 2008) 
and increases anxiety behavior (Bitran et al., 1993; Adler et al., 
1999; Frye and Seliga, 2001; Fernandez-Guasti and Martinez-Mota, 
2003) of rats across a variety of tasks. These negative effects of 
GDX on cognitive and affective behavior can be ameliorated, in 
part, through systemic T administration (Frye and Seliga, 2001; 
Fernandez-Guasti and Martinez-Mota, 2003; Sandstrom et  al., 
2006). However, some studies have found divergent and/or less 
robust results in studies of androgens and cognitive and affective 
performance (Naghdi et al., 2003; Spritzer et al., 2008; Mohaddes 
et al., 2009). Thus, the mechanisms for androgens’ effects on these 
hippocampally-inﬂ  uenced processes are of interest, and can be 
investigated further in animal models.
A question is the role of T’s metabolism through aging, which 
may account for some of the divergent effects found in stud-
ies of cognitive and affective performance of males. T can be 
aromatized to estrogen, which has long been thought to be a 
mechanism through which T exerts beneﬁ  cial behavioral effects. 
Estrogen can enhance cognitive and affective processes in women 
(Nathorst-Boos et al., 1993; Pearlstein et al., 1997; Drake et al., 
2000; Sherwin, 2002) and female rats (as reviewed in Daniel et al., 
1997; Frick et al., 2002; Frye and Rhodes, 2002; Daniel, 2006; 
Gresack and Frick, 2006; as reviewed in Palermo-Neto and Dorce, 
1990; Sandstrom and Williams, 2001, 2004; Walf and Frye, 2005, 
2006; Wallace et al., 2006; Luine, 2008). More recent research has 
looked at the effects of estrogen on age-induced memory deﬁ  -
cits. These ﬁ  ndings suggest that estrogen administration is more 
effective at restoring cognitive performance in female rodents 
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Experiments 2 and 3, 4-, 13-, and 24-month-old rats were left 
intact so that the question of whether androgen-replacement to 
aged rats with natural decline in steroid levels could ameliorate 
the behavioral deﬁ  cits observed with aging in Experiment 1 could 
be addressed. In Experiment 2, preliminary data were collected 
in a small group of 4-, 13-, and 24-month-old rats that were left 
gonadally-intact and administered subcutaneous (SC) injections 
of T or sesame oil vehicle immediately following training in the 
aforementioned cognitive tasks, or 1 h prior to testing in the anxi-
ety and depressive tasks, to begin to ascertain timing-dependent 
effects of T-replacement. In Experiment 3, the responsiveness of 
rats to 3α-diol was elucidated by comparing effects of admin-
istering acute, SC injections of 3α-diol or sesame oil vehicle 
immediately following training in the aforementioned cognitive 
tasks, or 1 h prior to testing in the anxiety and depressive tasks. 
Plasma and hippocampal levels of androgens were determined, 
and 5α-reductase activity was assessed in some samples to further 
address the role of androgen metabolism in the hippocampus for 
these behavioral effects. Together, the results from these experi-
ments suggest that age is associated with a decrease in 3α-diol 
production and 3α-diol administration reinstates cognitive and 
affective performance of aged male rats.
MATERIALS AND METHODS
All methods used were approved by the Institutional Animal Care 
and Use Committee at The University at Albany-SUNY and adhered 
strictly to the National Institutes of Health Guide for the Care 
and Use of Laboratory Animals (National Institutes of Health 
Publications, no. 80–23, revised 1978).
ANIMALS AND HOUSING
Subjects (N = 248) were adult male Fisher-344 rats, which were 
obtained from the National Institute of Aging aged animal col-
ony. Rats were grouped by age, such that rats that were 4 months 
(n = 97), 13 months (n = 77), or 24 months (n = 71) old were 
included in these experiments. Experimental rats were housed 
two to three per cage (45 × 24 × 21 cm), which contained wood-
chip shavings for bedding, in a temperature-controlled room 
(21 ± 1°C) in the Social Sciences Laboratory Animal Care Facility 
at The University at Albany-SUNY. The rats lived in a 12/12-h 
reversed light cycle (lights off at 8:00 h) with unlimited access to 
Purina Rodent Chow and tap water in their home cages. All of 
the data from these experiments are reported, but due to attri-
tion or health status of aged animals, group size varied across 
experimental tasks and neuroendocrine analyses. Initial group 
numbers are reported below. Separate groups of rats were used 
in Experiments 1 (n = 156), 2 (n = 18), and 3 (n = 71). Rats 
were handled consistently for cage cleaning and by experiment-
ers. Speciﬁ  cally, rats were picked up and placed in a new cage 
once weekly by animal care staff in the Laboratory Animal Care 
Facility at The University at Albany-SUNY. In Experiment 1, rats 
were handled by trained experimenters for the same number of 
times and duration weekly for surgery or sham surgery, behavioral 
testing, and tissue collection. In Experiments 2 and 3, rats were 
handled by trained experimenters for the same number of times 
and duration weekly for androgen or vehicle injections, behavioral 
testing, and tissue collection.
HORMONE MILIEU
Experiment 1
Rats in each age group were randomly assigned to one of three 
androgen groups: intact (4 months, n = 22; 13 months, n = 14; 
24 months, n = 14), GDX (4 months, n = 23; 13 months, n = 18; 
24 months, n = 15), or GDX with T implants (4 months, n = 21; 
13 months, n = 15; 24 months, n = 14). All rats were anesthe-
tized with xylazine (60  mg/kg) and ketamine (80  mg/kg) for 
GDX (n = 106) or sham surgery (n = 50). Of these rats, some 
(n = 50) received a single silastic capsule (1.57 mm inner diam-
eter, 3.18 mm outer diameter) containing crystalline T (Sigma, 
St. Louis; 10 mm/animal) to provide a sustained amount of T 
during behavioral testing. Behavioral testing began 1 week fol-
lowing implantation and continued for 4 weeks following. This 
regimen produces physiological levels of circulating T (Frye 
and Seliga, 2001) for the duration of testing. Rats that did not 
receive a T implant received an empty silastic capsule of the 
same dimensions.
Experiment 2
As there were no differences between aged (24 months old) intact 
and GDX rats in Experiment 1, and previous experiments have 
examined the effects of T and 3α-diol administration to GDX rats 
on cognitive and affective behavior (Edinger and Frye, 2004, 2005), 
only gonadally-intact rats were used in the subsequent studies. 
Using gonadally-intact rats, we were able to assess the effects of 
androgen decline and replacement in aging populations. In this 
experiment, the effects of acute T dosing were determined in a 
small group of rats. A separate group of intact rats from each age 
group were randomly assigned to receive a 1 mg/kg SC injection of 
T (4 months, n = 3; 13 months, n = 3; 24 months, n = 3) or sesame 
oil vehicle (4 months, n = 4; 13 months, n = 3; 24 months, n = 2) 
1 h before testing in the anxiety tasks, and immediately following 
training in the cognitive tasks. This T regimen, when adminis-
tered to young GDX rats (Edinger and Frye, 2004, 2005), or aged 
male mice (Frye et al., 2008), produces levels of androgens in the 
plasma and hippocampus that are akin to that of their young adult 
gonadally-intact counterparts. This regimen was used to produce 
physiological levels of T-replacement among aging rats. Because 
rats were left gondally-intact, androgen levels were assessed with 
these regimen.
Experiment 3
A separate group of gonadally-intact rats from each age group 
were randomly assigned to receive a 1 mg/kg SC injection of 3α-
diol (4 months, n = 12; 13 months, n = 12; 24 months, n = 11) 
or sesame oil vehicle (4  months, n = 12;  13 months,  n = 12; 
24 months, n = 12) 1 h before testing in the anxiety tasks, and 
immediately following training in the cognitive tasks. This 3α-
diol regimen, when administered to young GDX rats (Edinger 
and Frye, 2004, 2005), or aged male mice (Frye et al., 2009), 
produces levels of androgens in the plasma and hippocampus 
that are akin to that of their young gonadally-intact counter-
parts. As in Experiment 2, this regimen was used to produce 
physiological levels of T-replacement among aging rats. Because 
rats were left gondally-intact, androgen levels were assessed with 
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BEHAVIORAL TESTING
Rats were assessed in one task (the inhibitory avoidance, defensive 
freezing, forced swim test, and Morris Water maze) per week over 
a period of 4 weeks. All rats that survived testing were assessed in 
each task, and rats were tested on only one occasion. Rats in each 
cohort and experiment were assessed in these tasks in the same 
order: inhibitory avoidance, water maze, defensive freezing and 
forced swimming test.
Inhibitory avoidance
The inhibitory avoidance task was used as per previous methods 
to assess hippocampally-inﬂ  uenced cognitive performance (Frye 
and McCormick, 2000b). A stainless steel box was divided into 
two compartments (14 × 18 × 19 cm each) with a guillotine door. 
One side was painted white and brightly lit from above, while the 
other side was painted black and covered to block light. Day One 
(Habituation and Training): Each rat was placed in the white cham-
ber with their head facing the closed door and allowed to explore 
for 2 min. Following habituation of all animals, each rat was placed 
in the white chamber (with the door down) for 1 min. The door 
was opened, and the latency to crossover to the dark chamber was 
recorded (maximum latency of 20 min). The door was closed and 
rats received a mild shock (0.25 mA, 2-s duration). Flinch-jump 
scores (0 = no response, 1 = ﬂ  inch, 2 = movement of two paws, 
3 = jump/movement of four paws, 4 = jump and squeak) were 
recorded and the means are in Table 1. Of note, clear differences 
in ﬂ  inch-jump scores were not noted due to age or hormone con-
dition. Rats that did not crossover during training were excluded 
from data analyses. Day Two (Testing): Twenty-four hours later, rats 
were placed in the white chamber for 1 min. The door was lifted 
and the latency to crossover to the dark side was recorded (maxi-
mum latency of 5 min). Crossover latency was used as a measure 
of cognitive performance.
Water maze
The Morris Water Maze was used to assess hippocampally-
 inﬂ  uenced cognitive performance (Bennett et al., 2006). Day One 
(Habituation): A large circular water tank (175 cm diameter, 71 cm 
deep) was ﬁ  lled with water (20–25°C), and visually divided into 
four quadrants. White toxic-free tempera paint was added to the 
water to make it appear opaque. Rats were placed one at a time 
into the pool, without the platform in it, to become habituated to 
swimming for 1 min each. Day Two (Training): A clear Plexiglas 
platform (5.3 cm × 5.3 cm) was placed in one of the quadrants, 
30 cm from the side of the pool and 2.5 cm below the surface of 
the water. White toxic-free tempera paint was added to the water 
to make it appear opaque and obscure the platform. The rat was 
placed in one of the four quadrants of the pool and given 2 min 
to ﬁ  nd the hidden platform on two training trials. If the rat did 
not ﬁ  nd the platform, it was placed on the platform by the experi-
menter. The rat remained on the platform for 45 s after reaching it. 
Day Three (Testing): The pool was ﬁ  lled to the same height, with 
the platform placed in the original location in the pool. Tempera 
paint was added and the rat was placed into one of the quadrants. 
Quadrant placement was counterbalanced across four trials. The 
amount of time it took the animal to ﬁ  nd the hidden platform, and 
the distances traveled in the maze before ﬁ  nding it, were considered 
indices of performance on Day Three. On each trial, if the rat did 
not ﬁ  nd the platform, it was placed on the platform by the experi-
menter. The rat remained on the platform for 45 s after reaching 
it. The mean latencies for rats to reach the platform across trials is 
indicated in insets in Figures 1, 3, and 5 to demonstrate learning 
curves for rats using this measure. During both training and test-
ing, the distances swam in the pool and the latencies were used to 
calculate the average swim speed in each trial.
Defensive freezing
The defensive freezing test utilized previous methods to assess anxi-
ety in responses to a shock stimulus (Frye et al., 2000). Rats were 
placed in the test apparatus (26.0 × 21.2 × 24.7 cm) constructed of 
clear Plexiglas. An electriﬁ  ed probe (2.5 cm in diameter, 10.0 cm 
high) was placed 3.0 cm from the back wall and 2.5 cm from the 
right wall of the chamber. Wood chip bedding was placed in a 
5.0 cm-deep layer, with the probe extending 4.5 cm above the 
bedding. The probe was set to deliver a single, brief, 6.66 mA 
unscrambled shock when both forepaws made contact. The shock 
was terminated as soon as the rat removed its paws from the probe. 
The response to footshock was recorded by the experimenter as a 
ﬂ  inch-jump rating (0 = no response, 1 = ﬂ  inch, 2 = movement of 
two paws, 3 = jump/movement of four paws, 4 = jump and squeak). 
Latency to touch the probe, duration burying, and duration freez-
ing were recorded.
Forced swim test
Previous methods for the forced swim test were utilized to assess 
depressive-like behavior of rats (Walf et al., 2004). Rats were placed 
in a cylindrical chamber (45 cm high, 20 cm diameter) contain-
ing 30°C tap water to a level of 30 cm. The time spent struggling, 
swimming, and immobile was recorded during the 10-min test. 
Immobility indicates increased depressive-like behavior.
TISSUE COLLECTION
In Experiment 1, some rats at each age and hormone condition 
(GDX, intact, and T-replaced) were randomly-assigned to be 
rapidly decapitated, trunk blood was collected, and whole brains 
were immediately extracted from the skull and frozen on dry ice, 
according to previously published methods (Frye et al., 2000). 
Tissue was stored at –70°C until radioimmunoassay. Plasma hor-
mone levels were measured in GDX (4 months, n = 12; 13 months, 
n = 17; 24 months, n = 10), intact (4 months, n = 14; 13 months, 
n = 16; 24 months, n = 13) and T-replaced rats (4 months, n = 7; 
13 months, n = 12; 24 months, n = 6). The hippocampus of GDX 
(4 months, n = 5; 13 months, n = 13; 24 months, n = 9), intact 
(4 months, n = 9; 13 months, n = 12; 24 months, n = 11), and T-
replaced (4 months, n = 5; 13 months, n = 14; 24 months, n = 10) 
were assessed for steroid hormone levels and 5α-reductase activ-
ity. In Experiment 2, rats were administered SC T (4 months, 
n = 4; 13 months, n = 3; 24 months, n = 3) or vehicle (4 months, 
n = 3; 13 months, n = 3; 24 months, n = 2) and euthanized 1 h 
later, a time analogous to testing in the affective tasks. Similarly, 
in Experiment 3, a week following testing, rats were administered 
SC 3α-diol (4 months, n = 6; 13 months, n = 7; 24 months, n = 7) 
or vehicle (4 months, n = 6; 13 months, n = 6; 24 months, n = 5) 
and euthanized 1 h later. Tissues were collected and stored as in Frontiers in Aging Neuroscience  www.frontiersin.org  April 2010  | Volume 2  |  Article 15  |  5
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Experiment 1. T, DHT, 3α-diol, and estradiol (E2) were measured 
by radioimmunoassay in Experiments 1 and 2, and T, DHT, and 
3α-diol were measured in Experiment 3 (as described in Frye 
and Bayon, 1999). Plasma corticosterone levels were also meas-
ured by radioimmunoassay in Experiment 1 (as described in Frye 
and Bayon, 1999). Due to limitations on animal numbers and 
resources, rats were randomly chosen for tissue collection from 
groups that survived the duration of testing, and were not included 
in another experiment.
ANDROGEN RADIOIMMUNOASSAY
Androgens were extracted from plasma with diethyl ether and trace 
amounts of 3H ligand (Perkin Elmer). Brain tissue was homogenized 
with a glass/teﬂ  on homogenizer in distilled water. Androgens were 
extracted from the homogenate with diethyl ether and dried down 
in a savant. For plasma and brain samples, the ether was evapo-
rated, and the pellets were reconstituted in phosphate assay buffer 
(pH = 7.4). Plasma and hippocampal concentrations of T (T3-125; 
Esoterix Endocrinology, Calabasas Hills, CA, 1:20,000), DHT (DT3-
351; Esoterix Endocrinology, 1:20,000), 3α-diol (X-144; Dr. PN Rao, 
Southwest Foundation for Biomedical Research, San Antonio, TX), 
and E2 (#244; Dr. Niswender, Colorado State University, Fort Collins, 
CO) were measured according to previously published methods 
(Frye and Bayon, 1999; Frye et al., 2008). The T and DHT assay 
were incubated overnight at 4°C and the 3α-diol assay was incu-
bated overnight at room temperature. The E2 assay was incubated at 
room temperature for 50 min. After incubation, cold  dextran-coated 
charcoal was rapidly added for separation of bound and free ster-
oid. After charcoal incubation, samples were centrifuged at 3000× g. 
The supernatant was transferred to a glass scintillation vial with 
scintillation cocktail (Scintiverse BD) and samples were counted. 
Unknowns were interpolated from the standard curve using Assay 
Zap, a program for radioimmunoassay analyses.
CORTICOSTERONE RADIOIMMUNOASSAY
Corticosterone was measured in a subset of samples from 
Experiment 1 to determine stress-mediated effects on cognitive 
and affective performance. Results of this experiment did not sug-
gest that there were big group differences so corticosterone was 
not measured in Experiments 2 and 3. For extraction, plasma was 
heated to 60°C for 30 min. Samples were incubated for 60 min 
at room temperature with 3H corticosterone (NET 182: speciﬁ  c 
activity = 48.2 ci/mmol; Perkin Elmer) and a 1:20 000 dilution of 
antibody (Esoterix Endocrinology:#B3-163; Frye and Bayon, 1999). 
Dextran-coated charcoal was used to separate bound and free fol-
lowing incubation (15-min) on ice and centrifugation at 3000× g 
for 10 min. Supernatant was decanted into a glass scintillation vial 
with scintillation cocktail and then counted. Unknowns were inter-
polated from the standard curve using Assay Zap.
5α-REDUCTASE ACTIVITY
Hippocampal tissues from a small number of subjects in Experiments 
1 and 2 were assessed for 5α-reductase activity given that results of 
the radioimmunoassay of these experiments suggested that there 
may be differences in T metabolite levels. Steroid metabolic conver-
sion was quantiﬁ  ed in tissue fragments from the unilateral dorsal 
hippocampus by thin-layer chromatography (in Dr. Edwin Lephart’s 
laboratory, Brigham Young University). 3H T was added as the sub-
strate (at a saturating concentration of 1.75 µM) and incubated at 
1 h at 37°C in Eagle’s minimal essential medium (EMEM; pH 7.4; 
Grand Island Biological Co.) in an atmosphere of 95% O2–5% CO2. 
After 1 h, androgens were extracted using chloroform. Aliquots 
(100 µl) of the organic-chloroform phase were evaporated to dry-
ness, redissolved in 30 µl containing 10 µg of T, DHT or 3α-diol, 
and applied to silica gel, plastic sheets. The plates were developed 
using dichloromethane (85%): ethyl acetate (15%): methanol (3%), 
which resolves the major 5α-reduced metabolites from estradiol, 
estrone, and 5β-metabolites. Androgens were visualized by spray-
ing with water, and the areas within each lane corresponding to the 
reference steroids are marked. By isolating within each lane, from 
the origin to the solvent front, and assaying for 3H, procedural 
losses are accounted for. The radioactivity recovered in the areas 
of each lane corresponding to the cold androgen standards were 
used to calculate activity rates which are expressed as a fraction of 
the total radioactivity recovered multiplied by the concentration 
of 3H T added. This revealed the enzymatic rate expressed in total 
5α-reductase activity (pmol/hr/mg/protein; Lephart and Ojeda, 
1990; Lephart et al., 1990, 2001; Table 4). Furthermore, ratios of 
DHT and 3α-diol to T, and 3α-diol to DHT, were calculated based 
upon radioimmunoassay results as an index of 5α-reductase and 
3α-HSD conversion, respectively (Table 4).
STATISTICAL ANALYSES
Two-way analyses of variance (ANOVAs) were used to assess main 
effects of age (4 months, 13 months, 24 months) and androgen 
condition (intact, GDX, GDX  + T,  intact + 3α-diol, intact  + T) 
on behavioral and neuroendocrine measures in Experiments 1–3. 
Interactions between these two factors were also assessed and are 
reported. Where appropriate, Fisher’s post hoc tests were used to 
assess differences between groups. The α level for statistical signiﬁ  -
cance for main effects, interactions, and post hoc tests was a p-value 
of <0.05 and a trend was considered when p = 0.05–0.075.
RESULTS
EXPERIMENT 1: EFFECTS OF AGING, GDX, AND CHRONIC 
T-REPLACEMENT ON COGNITIVE AND AFFECTIVE BEHAVIOR AND 
PLASMA AND/OR HIPPOCAMPUS STEROID LEVELS
Inhibitory avoidance
Training. There was a main effect of age [F(2,135) = 5.88, p < 0.01; 
Table 1], but not hormone condition, to increase training crossover 
latencies. There were no effects of either age or hormone condition 
on ﬂ  inch-jump ratings in response to footshock during training 
(Table 1).
 Testing. During testing, there was a main effect of age [F(2,135) = 7.2, 
p < 0.01; Figure 1A] such that 4- (p < 0.01) and 13-month-old 
(p < 0.01) rats had signiﬁ  cantly longer latencies to crossover to 
the shock-associated chamber than did 24-month-old rats. There 
was also a main effect of hormone condition [F(2, 135) = 9.7, 
p < 0.01], such that GDX decreased latencies compared to intact 
(p < 0.01) and T-replaced rats (p < 0.05). The interaction between 
these variables was not statistically signiﬁ  cant, but effects of hor-
mone condition were most apparent in 4- and 13-, compared to 
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Water maze
Training: There were no signiﬁ  cant effects of age or hormone 
condition for latencies to the platform during training or swim 
speed during the two training trials (Table 2). However, there was 
a signiﬁ  cant interaction between variables for distance swum in 
the water maze during training [F(4,84) = 3.06, p < 0.02; Table 2]. 
The interaction demonstrated that 13- and 24-month-old rats 
that were gonadally-intact, and 13-month-old rats that were GDX 
and T-replaced, swam the greatest distances in the water maze 
during training.
Testing.  There was a main effect of age for latencies 
[F(2,84) = 31.31,  p < 0.01;  Figure 1B] and distances swam 
[F(2,84) = 9.92,  p < 0.01;  Table 2]. Four-month-old rats had 
signiﬁ  cantly shorter latencies to ﬁ  nd the hidden platform on 
testing day compared to 13- (p < 0.01) and 24-month (p < 0.01) 
old rats. Four-month-old rats also swam signiﬁ  cantly shorter 
distances to ﬁ  nd the hidden platform on testing day compared 
to 13- (p < 0.01) and 24-month (p < 0.01) old rats. Hormone 
condition and age interacted for latencies [F(4,84) = 3.14, 
p = 0.02], but not distances, such that GDX decreased latencies 
of 13-month-old, but not 4- or 24-month-old, intact rats. There 
was no signiﬁ  cant main effect of androgen condition during 
testing for latencies to reach the hidden platform; however, there 
was a tendency for hormone condition to alter distances that 
rats swam to the platform [F(2,84) = 2.72, p = 0.07], such that 
intact rats had longer distances than did GDX rats (p = 0.07). 
There was a main effect of age [F(2,84) = 8.62, p < 0.01], and a 
tendency for an interaction between age and hormone condi-
tion [F(4,84) = 2.36, p < 0.06], for swim speed during the testing 
trials, such that 4-month-old rats, particularly those that were 
GDX and T-replaced, had increased swim speed, compared to 
13- and 24-month-old rats.
Defensive freezing
There was a main effect of age [F(2,117) = 11.38, p < 0.01; Figure 1C] 
such that 4-month-old rats spent signiﬁ  cantly less time freezing 
in response to a shock compared to 13- (p < 0.01) or 24-month 
(p < 0.01) old rats. Additionally, a main effect of androgen con-
dition [F(2,117) = 3.80, p = 0.02] illustrated that GDX increased 
(p = 0.05) time spent freezing compared to intact or T-replaced 
rats. Moreover, there was a signiﬁ  cant interaction between age and 
androgen condition [F(4,117) = 5.42, p = 0.01], such that GDX 
increased freezing in 4-, but not 13- or 24-, month-old rats, com-
pared to intact rats or those that were T-replaced. There were no 
main effects of age or androgen condition or interactions between 
these variables for duration burying, latency to touch the electriﬁ  ed 
probe, or ﬂ  inch-jump rating (Table 3).
Forced swim task
A main effect of age [F(2,129) = 51.5, p < 0.01; Figure 1D] demon-
strated that 4-month-old rats spent signiﬁ  cantly less time immobile 
compared to 13- (p < 0.01) and 24-month (p < 0.01) old rats. There 
was also a main effect of androgen condition [F(2,129) = 22.6, 
p < 0.01], such that GDX increased (p < 0.01) immobility com-
pared to intact or T-replaced rats. The interaction between age and 
hormone condition [F(4,129) = 14.4, p < 0.01] was due to GDX 
increasing immobility in 4-month-old, but not 13- or 24-month-
old, rats, compared to intact rats.
There was a main effect of age on time spent struggling 
[F(2,129) = 9.80,  p < 0.01;  Table 3] such that 4-month-old 
rats spent more time struggling than did 13- (p = 0.04) and 
24-month (p < 0.01) old rats. There was no effect of hormone 
condition on time spent struggling, or an interaction between 
these variables.
A main effect of age on swimming [F(2,129 = 14.90, p < 0.01] 
revealed more swimming among 4-month-old rats, compared to 
13- (p < 0.01) and 24-month (p < 0.01) old rats. There was also a 
main effect of androgen condition on swimming [F(4,129) = 10.45, 
p < 0.01], such that, compared to intact rats, GDX (p < 0.01) rats 
spent signiﬁ  cantly more time swimming. There was a signiﬁ  -
cant interaction of age and androgen condition [F(4,129) = 2.02, 
p = 0.02], with GDX decreasing swimming in 4- and 13-, but not 
24-, month-old, rats, compared to intact rats.
Table 1 | Other measures in the inhibitory avoidance tasks of 4-, 13-, and 
24-month-old gonadally-intact (intact), gonadectomized (GDX), or GDX 
and T-replaced (GDX + T; Experiment 1), intact and T-administered 
(Experiment 2), and intact or intact or intact and 3α-diol-administered 
(Experiment 3) rats. Measures are: latency to shock-associated side during 
training in the inhibitory avoidance task (mean ± SEM), and ﬂ  inch-jump 
ratings (mean ± SEM) in response to footshock during training in this task.
Age Steroid  Inhibitory    Inhibitory
 condition  avoidance  avoidance 
   training  Flinch-jump
   latency  (s)  rating
EXPERIMENT 1
4 Months  Intact  65.1 ± 20.9*  3.4 ± 0.3
 GDX  92.7  ± 51.9*  2.8 ± 0.3
 GDX  + T  33.6 ± 10.3*  2.2 ± 0.2
13 Months  Intact  236.6 ± 64.8  2.3 ± 0.3
 GDX  219.8  ± 59.6  2.4 ± 0.3
 GDX  + T  126.6 ± 27 .9  2.7 ± 0.3
24 Months  Intact  173.1 ± 66.7  2.7 ± 0.4
 GDX  158.1  ± 94.4  2.2 ± 0.2
 GDX  + T  122.6 ± 62.1  2.5 ± 0.2
EXPERIMENT 2
4 Months  Intact  166.7 ± 38.9  3.3 ± 0.7
 Intact  + T  128.5 ± 39.5  2.5 ± 0.3
13 Months  Intact  120.3 ± 65.2  1.7 ± 0.3
 Intact  + T  210.3 ± 34.4  2.3 ± 0.3
24 Months  Intact  88.0 ± 13.0  3.0 ± 1.0
 Intact  + T  163.3 ± 77 .9  2.3 ± 0.3
EXPERIMENT 3
4 Months  Intact  29.4 ± 19.9*  2.4 ± 0.3
 Intact  + 3α-diol 26.1  ± 13.2*  2.4 ± 0.3
13 Months  Intact  112.4 ± 30.3  3.1 ± 0.3
 Intact  + 3α-diol 57 .4  ± 19.7  2.8 ± 0.3
24 Months  Intact  20.6 ± 4.2  2.4 ± 0.2
 Intact  + 3α-diol 72.6  ± 31.1  3.2 ± 0.3
*Denotes signiﬁ  cant difference from 13- or 24-month-old rats (p < 0.05).Frontiers in Aging Neuroscience  www.frontiersin.org  April 2010  | Volume 2  |  Article 15  |  7
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Androgen and corticosterone levels (Figure 2, Tables 4 and 5)
Age did not signiﬁ  cantly alter plasma T levels, but there was a non-
signiﬁ  cant pattern for 4-month-old rats to have the highest plasma 
T levels than did older rats [F(2,92) = 2.48, p = 0.08; Table 4]. 
There was a main effect of hormone status on plasma T levels 
[F(2,92) = 4.13, p = 0.02; Table 4]. This was due to GDX decreas-
ing plasma (p = 0.01) T levels, compared to intact rats, which had 
similar levels as those that were GDX and T-replaced. There were no 
signiﬁ  cant interactions between variables for plasma T levels. There 
was a main effect of androgen condition [F(2,92) = 9.2, p < 0.01], 
but not age, on E2 levels such that GDX rats had signiﬁ  cantly lower 
(p < 0.01) plasma levels than did GDX + T-replaced rats (Table 4). 
Plasma DHT levels were not altered by age or hormone condition 
(Table 4). There was a signiﬁ  cant main effect of age on 3α-diol levels 
in plasma [F(2,92) = 20.86, p < 0.01], such that 4-month-old rats 
had signiﬁ  cantly greater levels than 13-month-old rats (p < 0.01) 
and 24-month-old (p = 0.01) rats. A main effect of androgen condi-
tion on plasma [F(2,92) = 10.21, p < 0.01] 3α-diol levels was due 
to GDX signiﬁ  cantly decreasing plasma (p < 0.01) 3α-diol levels 
compared to intact rats, and T administration reinstating plasma 
(p < 0.01) 3α-diol levels similar to levels observed among intact 
rats (Table 4). Age and hormone condition signiﬁ  cantly interacted 
for plasma [F(4,92) = 2.75, p = 0.03] 3α-diol levels, such that GDX 
decreased 3α-diol levels in 4- and 13-, but not 24-, month-old rats 
(Table 4). There was no effect of age or hormone status on plasma 
corticosterone levels (Table 4).
There was a main effect of hormone status, but not age, on hip-
pocampal [F(2,79) = 5.4, p = 0.01] T levels (Figure 2A). This was 
due to GDX decreasing hippocampal (p = 0.04) levels of T, com-
pared to intact rats. A signiﬁ  cant interaction of age and hormone 
condition [F(4,79) = 2.5, p = 0.04] was due to GDX decreasing 
hippocampal T in 4-month-old (p = 0.04), but not 13- or 24-
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FIGURE 1 | Represents behavior of 4- (black bars), 13- (dark grey bars), 
and 24- (light grey bars) month-old rats that were left intact (solid bars), 
GDX (white bars), or GDX and T-replaced (striped bars) in the 
inhibitory avoidance task (A), water maze (B), defensive freezing 
task (C), and forced swim task (D). * over individual bars denotes 
signiﬁ  cant difference (p < 0.05) of GDX rats compared to intact and T-replaced 
rats (p < 0.05). # above individual bars indicates a tendency to be different 
from intact rats (p < 0.075).* over brackets denotes difference at that age 
group compared to age groups that do not have a bracket above bars 
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month-old rats. There was no main effect of androgen condition 
or age for hippocampal E2 (Figure 2B) or DHT (Figure 2C) levels. 
There was a signiﬁ  cant main effect of age on 3α-diol levels in the 
hippocampus [F(2,79) = 8.46, p < 0.01], such that 4- (p = 0.01) 
and 13- (p < 0.01) month-old rats had signiﬁ  cantly greater levels 
than 24-month-old rats (Figure 2D). A main effect of androgen 
condition on hippocampal [F(2,79) = 5.15, p = 0.01] 3α-diol levels 
was due to GDX signiﬁ  cantly decreasing levels compared to those 
observed in intact rats (Figure 2D). Age and hormone condition 
signiﬁ  cantly interacted for hippocampal [F(4,79) = 4.7, p < 0.01] 
3α-diol levels, such that GDX decreased 3α-diol levels in 4-, but 
not 13- or 24-month-old, rats (Figure 2D).
Although the analyses of conversion ratios did not reveal statisti-
cally signiﬁ  cant differences based upon age or hormone condition 
for 5α-reductase activity, intact 24-month-old rats had the highest 
activity compared to other groups, and GDX, with or without T-
replacement, reduced conversion (Table 5). A similar pattern was 
observed in the GDX and GDX + T 13- and 24-month-old groups, 
but effects did not reach statistical signiﬁ  cance for 5α-reductase 
activity, as measured by the thin-layer chromatography method 
(Table 5). There was a trend for an effect of age on 3α-HSD activity, 
based upon conversion ratios of 3α-diol to DHT, such that activ-
ity tended to be increased in 13-month-old rats [F(2,79) = 2.91, 
p = 0.06] compared to 4-month-old rats.
EXPERIMENT 2: EFFECTS OF AGING AND ACUTE T-REPLACEMENT ON 
COGNITIVE AND AFFECTIVE BEHAVIOR AND ANDROGEN LEVELS IN 
CIRCULATION AND IN THE HIPPOCAMPUS
 Inhibitory avoidance
Training. Age, T administration, or an interaction between these 
variables did not alter training crossover latencies, or ﬂ  inch-jump 
responses to footshock during training (Table 1).
Testing. T administration did not alter crossover latencies during 
testing. There was a main effect of age [F(2,12) = 5.87, p = 0.02; 
Figure 3A], such that 4-month-old rats had signiﬁ  cantly increased 
latencies to crossover to the shock-associated side of the chamber 
compared to 13- (p = 0.07) and 24-month (p < 0.01) old rats during 
testing trials. There were no signiﬁ  cant interaction between these 
variables for crossover latencies.
Table 2 | Other measures in the water maze tasks of 4-, 13-, and 24-month-old gonadally-intact (intact), gonadectomized (GDX), or GDX and 
T-replaced (GDX +   T; Experiment 1), intact and T-administered (Experiment 2), and intact or intact or intact and 3α-diol-administered (Experiment 3) 
rats. Measures are: latency, swim speed, and distances traveled during training in the water maze (mean ± SEM averaged over two trials) and swim speed 
and distances traveled during testing (mean ± SEM averaged over four trials).
Age  Steroid   Water maze   Water maze   Water maze   Water maze   Water maze
  condition  training  training   testing   training speed  testing speed
   latency  (s)  distance  distance  (cm/s)  (cm/s)
EXPERIMENT 1 
4 Months  Intact  84.9 ± 9.6  1239.3 ± 183.0  941.8 ± 140.1*  16.3 ± 2.3  29.4 ± 4.5*
 GDX 78.6  ± 10.8  1417 .7 ± 238.9  1029.7 ± 155.0*  18.0 ± 1.7  32.1 ± 9.3*
 GDX  + T   83.5 ± 8.0  1485.4 ± 231.5  961.7 ± 111.3*  21.1 ± 3.8  63.3 ± 12.4*
13 Months  Intact  89.1 ± 12.8  1756.0 ± 213.1  1649.9 ± 278.0# 21.0  ± 1.6  19.8 ± 1.5
 GDX 65.3  ± 11.8  1195.8 ± 142.9  1154.0 ± 208.3  19.8 ± 1.7  20.0 ± 2.9
 GDX  + T  98.9 ± 7 .2  1948.1 ± 184.5  1557 .6 ± 216.1  19.4 ± 1.7  17 .4 ± 1.1
24 Months  Intact  111.2 ± 8.6  1983.1 ± 141.0  2000.9 ± 169.1# 18.3  ± 0.9  21.2 ± 0.4
 GDX 96.1  ± 13.5  1769.9 ± 215.7  1368.0 ± 162.1  18.8 ± 0.9  15.0 ± 1.3
 GDX  + T  85.0 ± 12.4  1201.0 ± 161.2  1259.4 ± 112.6  16.4 ± 2.9  17 .7 ± 2.4
EXPERIMENT 2
4 Months  Intact  87 .6 ± 18.9  2208.1 ± 505.2  698.1 ± 126.9*  22.0 ± 2.3  44.8 ± 31.5
 Intact  + T  55.0 ± 24.5  1309.2 ± 614.0  511.7 ± 83.6*  19.7 ± 2.8  41.5 ± 9.2
13 Months  Intact  103.0 ± 17 .0  1944.2 ± 123.2  1120.0 ± 93.2  19.5 ± 2.3  23.8 ± 6.3
 Intact  + T  105.3 ± 14.7  1620.8 ± 319.7  1105.0 ± 178.9  17 .9 ± 7 .0  76.0 ± 36.7
24 Months  Intact  102.7 ± 17 .3  1375.0 ± 160.0  1679.4 ± 63.1  13.9 ± 3.8  15.4 ± 2.4
 Intact  + T  109.2 ± 10.8  1535.8 ± 276.7  1543.3 ± 58.4  14.3 ± 1.2  14.2 ± 0.4
EXPERIMENT 3
4 Months  Intact  50.9 ± 9.3*  1155.2 ± 195.8+ 535.0  ± 88.6*  20.8 ± 1.6  22.3 ± 3.5
 Intact  + 3α-diol 76.9  ± 9.4*#
  1505.2 ± 167.5+ 419.6  ± 59.6*  23.2 ± 2.0  18.6 ± 1.6
13 Months  Intact  90.4 ± 8.9  1689.6 ± 191.5  1145.2 ± 91.8  19.1 ± 0.9  19.4 ± 1.3
 Intact  + 3α-diol 92.3  ± 10.5  1796.0 ± 195.5  1038.5 ± 103.1  20.1 ± 1.4  19.7 ± 0.9
24 Months  Intact  86.5 ± 7 .5  1455.0 ± 128.5  1358.2 ± 134.6  33.4 ± 16.2  18.5 ± 2.6
 Intact  + 3α-diol 98.3  ± 6.3  1786.6 ± 201.5  1200.5 ± 209.7  18.0 ± 1.3  26.7 ± 9.3
*Denotes signiﬁ  cant difference from 13- and 24-month-old rats (p < 0.05). +Denotes trend for difference from 13 month-old rats (p = 0.5–0.75). #Denotes trend for 
difference from GDX or intact + vehicle (p = 0.5–0.75).Frontiers in Aging Neuroscience  www.frontiersin.org  April 2010  | Volume 2  |  Article 15  |  9
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Water maze
Training. Age, T administration, or an interaction between these 
variables did not alter training latencies, distances swam, or swim 
speed during training (Table 2).
 Testing. There was a main effect of age for latencies to the hid-
den platform [F(2,12) = 33.80, p < 0.01; Figure 3B] and distances 
swam [F(2,12) = 34.20, p < 0.01; Table 2] in the water maze dur-
ing testing. Four-month-old rats, compared to 24- (p < 0.01) and 
13-month-old rats (p = 0.01), had signiﬁ  cantly decreased latencies 
to the platform on testing day. Compared to 24-month-old rats, 
4- and 13-month-old rats swam signiﬁ  cantly shorter distances in 
the water maze during testing. Neither hormone condition, nor an 
interaction between these variables, altered latencies or distances 
swam. There were no signiﬁ  cant effects of age, hormone condition, 
or an interaction for swim speeds during testing (Table 2).
 Defensive freezing
Hormone condition (SC T) did not alter time freezing, but there 
was a main effect of age [F(2,12) = 10.20, p < 0.01; Figure 3C], 
demonstrating that 4- (p < 0.01) and 13-month (p = 0.01) old rats 
spent signiﬁ  cantly less time freezing in response to shock than did 
24-month-old rats. Age, hormone condition, or an interaction 
between these variables did not signiﬁ  cantly alter latency to touch 
the probe, duration burying, or ﬂ  inch-jump ratings (Table 3).
 Forced swim task
There was no signiﬁ  cant main effect of SC T for immobility in the 
forced swim test, but there was a main effect of age [F(2,12) = 6.30, 
p = 0.01;  Figure 3D], such that 4- (p < 0.01)  and  13-month 
(p = 0.01) old rats spent signiﬁ  cantly less time immobile than did 
24-month-old rats. Age and/or SC T did not alter time spent strug-
gling. There was a main effect of age [F(2,12) = 5.24, p = 0.02] for 
swimming, such that 4- (p = 0.01) and 13-month (p = 0.01) old rats 
spent more time swimming compared to 24-month-old rats. There 
was also a trend for an effect of androgen condition [F(1,12) = 3.85, 
p = 0.07], such that T administration (p = 0.06) tended to increase 
time spent swimming. There were no interactions of variables for 
any of these measures in the forced swim test.
 Androgen levels (Figure 4, Tables 4 and 5)
There was a main effect of age for plasma T levels [F(2,12) = 5.93, 
p = 0.01], such that 4-month-old rats had signiﬁ  cantly greater lev-
els than did 24-month (p = 0.01) old rats (Table 4). There was also 
Table 3 | Motor and shock response-behavior of 4-, 13-, and 24-month-old gondally-intact (intact), gonadectomized (GDX), or GDX and T-replaced 
(GDX +   T; Experiment 1), intact or intact and T-administered (Experiment 2), and intact or intact and 3α-diol administered (Experiment 3) rats in the 
forced swim (struggling and swimming duration) and defensive freezing (Flinch/jump, latency to shock, duration burying) tasks.
  Condition  Forced swim test  Defensive freezing task
Age  Steroid condition  Struggling duration  Swimming duration  Flinch/jump  Latency to shock  Duration burying
EXPERIMENT 1 
4 Months  Intact  167 .5 ± 9.6*  259.6 ± 17 .1*  2.0 ± 0.3  216.7 ± 69.3  141.3 ± 38.1
 GDX  100.9  ± 12.8*  161.7 ± 11.8*^ 2.0  ± 0.3  232.8 ± 84.9  57 .4 ± 19.3
 GDX  + T  168.1 ± 21.1*  266.9 ± 16.9*  1.8 ± 0.4  94.5 ± 73.3  82.7 ± 25.9
13 Months  Intact  105.1 ± 14.6  167 .8 ± 22.5  1.8 ± 0.2  80.4 ± 17 .8  78.6 ± 28.4
 GDX  106.1  ± 7 .8  145.1 ± 13.3^ 1.8  ± 0.3  146.1 ± 39.8  130.9 ± 60.0
 GDX  + T  124.1 ± 14.5  209.2 ± 17 .9  1.8 ± 0.3  210.0 ± 79.4  53.0 ± 23.8
24 Months  Intact  98.3 ± 10.3  150.4 ± 17 .1  1.5 ± 0.3  223.6 ± 92.4  79.3 ± 33.0
 GDX  115.4  ± 12.1   154.3 ± 15.2  2.6 ± 0.3  167 .7 ± 83.7  123.7 ± 50.7
 GDX  + T  85.5 ± 9.6  179.3 ± 14.2  2.3 ± 0.3  116.2 ± 43.2  109.3 ± 33.2
EXPERIMENT 2
4 Months  Intact  139.7 ± 32.8  151.7 ± 65.1  1.7 ± 0.3  100.0 ± 55.9  153.0 ± 153.0
 Intact  + T  193.3 ± 31.4  251.0 ± 15.6^ 2.0  ± 0.4  104.3 ± 37 .3  56.3 ± 32.4
13 Months  Intact  147 .3 ± 49.9  141.7 ± 21.6  2.0 ± 0.0  101.7 ± 85.7  0.0 ± 0.0
 Intact  + T  141.0 ± 46.1  242.5 ± 32.8^ 2.3  ± 0.3  109.7 ± 53.9  167 .3 ± 91.9
24 Months  Intact  110.0 ± 23.0  103.5 ± 32.5  2.5 ± 0.5  146.0 ± 85.0  0.0 ± 0.0
 Intact  + T  83.0 ± 11.1  77 .3 ± 9.4^ 1.7  ± 0.3  87 .3 ± 46.5  37 .0 ± 37 .0 
EXPERIMENT 3
4 Months  Intact  125.4 ± 18.5  205.8 ± 20.3  1.8 ± 0.3  103.1 ± 24.7  125.8 ± 56.2
 Intact  + 3α-diol 137 .0  ± 16.7^ 209.0  ± 16.7  1.7 ± 0.2  74.7 ± 21.0  152.3 ± 43.7
13 Months  Intact  86.8 ± 9.2  208.9 ± 26.3  2.3 ± 0.1  127 .8 ± 24.3  107 .9 ± 40.0
 Intact  + 3α-diol 146.9  ± 17 .1^ 273.8  ± 34.9  1.8 ± 0.1  96.8 ± 18.9  96.5 ± 40.6
24 Months  Intact  51.1 ± 14.8  196.9 ± 28.5  1.9 ± 0.2  111.6 ± 26.5  33.4 ± 14.8 
 Intact  + 3α-diol 122.4  ± 23.7^ 223.9  ± 32.8  1.6 ± 0.3  91.1 ± 34.7  293.5 ± 81.8
*Denotes signiﬁ  cant difference from 13- and 24-month-old rats (p < 0.05). ^Denotes signiﬁ  cant difference from intact or intact + vehicle groups (p < 0.05).Frontiers in Aging Neuroscience  www.frontiersin.org  April 2010  | Volume 2  |  Article 15  |  10
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a main effect of androgen condition on plasma [F(1,12) = 33.8, 
p < 0.01] T levels, such that T administration increased levels 
in plasma (p < 0.01) compared to vehicle (Table 4). There was 
no signiﬁ  cant interaction between these variables for plasma T 
levels. There was no signiﬁ  cant effect of age or T administra-
tion, nor an interaction, for plasma E2, DHT, or 3α-diol levels 
(Table 4).
There was also a main effect of androgen condition, but not 
age or an interaction between these variables, on hippocampal 
[F(1,12) = 9.45,  p =  0.01] T levels, such that T administration 
increased levels compared to vehicle (p = 0.01; Figure 4A). There 
was no signiﬁ  cant effect of age or T administration on hippocampal 
E2 or DHT levels (Figures 4B,C, respectively). Additionally, there 
was a main effect of age on hippocampal [F(2,12) = 8.36, p = 0.01] 
3α-diol levels, such that 4- (p < 0.01) and 13-month (p = 0.01) 
old rats had signiﬁ  cantly greater 3α-diol levels compared to 24-
month-old rats (Figure 4D). There was no effect of androgen con-
dition, or an interaction between variables, on 3α-diol levels in the 
hippocampus.
Age did not alter 5α-reductase activity, but there was a main 
effect of androgen condition [F(1,12) = 7.39, p = 0.02: Table 5], 
such that T administration (p = 0.02) decreased 5α-reductase activ-
ity. Although there were no statistically signiﬁ  cant main effects 
or interactions for 5α-reductase activity measured by thin-layer 
chromatography, a similar pattern as seen with conversion ratios 
was apparent (Table 5). There were no statistically signiﬁ  cant main 
effects or interactions on the conversion ratio of DHT to 3α-diol, 
as a proxy of 3α-HSD activity (Table 5).
EXPERIMENT 3: EFFECTS OF AGING AND ACUTE 3α-DIOL-REPLACEMENT 
ON COGNITIVE AND AFFECTIVE BEHAVIOR AND ANDROGEN LEVELS IN 
CIRCULATION AND IN THE HIPPOCAMPUS
Inhibitory avoidance
Training. There was a main effect of age on training crossover 
latencies [F(2,66) = 3.55, p = 0.03; Table 1] such that they were 
decreased in 4-month-old rats (p = 0.01), but there was no main 
effect of hormone condition or an interaction between variables 
on training latencies.
Testing. There were signiﬁ  cant main effects of age [F(2,66) = 11.49, 
p < 0.01; Figure 5A] and 3α-diol administration [F(1,66) = 11.41, 
p < 0.01], but not an interaction between variables, for testing cross-
over latencies. 4-month-old rats had signiﬁ  cantly higher (p < 0.01), 
and 13-month-old rats tended to have higher (p = 0.07), crossover 
latencies on testing day, compared to 24-month-old rats. 3α-diol 
increased crossover latencies compared to vehicle (p = 0.01).
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FIGURE 2 | Represents hippocampal levels of T (A), E2 (B), DHT (C), and 
3α-diol (D) in of 4- (black bars), 13- (dark grey bars), and 24- (light grey 
bars) month-old rats that were left intact (solid bars), GDX (white 
bars), or GDX and T-replaced (striped bars). * over individual bars 
denotes signiﬁ  cant difference (p < 0.05) of GDX rats compared to intact 
rats (p < 0.05). * over brackets denotes difference at that age group 
compared to age groups that do not have a bracket above bars 
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Water maze
Training. There was a signiﬁ  cant main effect of age on latencies 
[F(2,65) = 6.80, p = 0.02], and a trend towards signiﬁ  cance for dis-
tances traveled to ﬁ  nd the platform [F(2,65) = 2.77, p = 0.07], dur-
ing training. Four-month-old rats had signiﬁ  cantly shorter latencies 
compared to 13- and 24-month-old rats, and tended to have shorter 
distances traveled compared to 13-month-old rats, during training 
trials. There was a trend for 3α-diol condition to alter latencies, but 
not distances, during training, such that rats in the 3α-diol group 
tended to have decreased latencies to ﬁ  nd the platform during train-
ing (p = 0.07). There were no signiﬁ  cant interactions for latencies 
or distances swam during training. There was no signiﬁ  cant effect 
of age, androgen status, or an interaction between these variables 
for swim speed during training trials (Table 2).
Testing. There was a main effect of age on latencies [F(2,65) = 34.8, 
p < 0.01;  Figure 5B] and distances traveled [F(2,65) = 24.08, 
p < 0.01; Table 2] to ﬁ  nd the hidden platform during the testing 
trials, such that 4-month-old rats had signiﬁ  cantly lower laten-
cies and shorter distances swam than did 13- (p < 0.01) and 24- 
(p < 0.01) month-old rats, and 13-month-old rats had signiﬁ  cantly 
lower latencies and distances than did 24-month-old rats (p = 0.01, 
p < 0.01). A main effect of androgen condition [F(1,65) = 5.32, 
p = 0.02] was due to 3α-diol administration signiﬁ  cantly   decreasing 
latencies to the platform during testing compared to vehicle 
(p = 0.02; Figure 5B). There was no interaction of variables for 
latencies or distances, and distances were not signiﬁ  cantly altered 
by androgen condition. There was no signiﬁ  cant effect of age, 
androgen status, or an interaction for swim speed during testing 
trials (Table 2).
Defensive freezing
There was a signiﬁ  cant main effect for age [F(2,58) = 3.99, p = 0.02; 
Figure 5C] in the defensive freezing task such that 4-month-old 
rats spent signiﬁ  cantly less time freezing in response to shock than 
did 13-month-old rats (p = 0.01), and tended to spend less time 
freezing than 24-month-old rats (p = 0.05). There was also a signiﬁ  -
cant main effect of androgen condition [F(1,58) = 25.75, p < 0.01]. 
Compared to vehicle, 3α-diol administration signiﬁ  cantly decreased 
time spent freezing (p < 0.01). There was an interaction between 
age and 3α-diol administration [F(2,58) = 3.09, p = 0.05], such that 
3α-diol decreased time spent freezing in 13- and 24-, but not 4-
month-old, rats. There was a main effect of 3α-diol administration 
[F(2,58) = 5.07, p = 0.02; Table 3], but not age or an interaction 
between variables, to increase time spent burying, compared to 
vehicle. Additionally, neither age, 3α-diol administration, nor an 
interaction of these variables altered latency to touch the electriﬁ  ed 
probe or ﬂ  inch-jump ratings (Table 3).
Table 4 | Plasma steroid levels of 4-, 13-, and 24-month-old gonadally-intact (intact), gonadectomized (GDX), or GDX and T-replaced (GDX + T; 
Experiment 1), intact or intact and T-administered (Experiment 2), and intact or intact and 3α-diol administered (Experiment 3) rats.
Age Steroid  condition  T (ng/ml)  E2 (pg/ml)  DHT (ng/ml)  3α-diol (ng/ml)  CORT (µg/dl)
EXPERIMENT 1 
4 Months  Intact  7 .0 ± 1.1*  0.6 ± 0.2  3.5 ± 0.3  1.9 ± 0.4*  2.9 ± 1.3
 GDX  3.5  ± 1.4*^ 1.2  ± 0.4 >   3.8 ± 0.9  0.8 ± 0.1*^ 2.7  ± 1.4
 GDX  + T   5.8 ± 2.6*  1.0 ± 0.4  3.3 ± 0.5  1.5 ± 0.3*  3.5 ± 2.2
13 Months  Intact  4.8 ± 0.7  0.7 ± 0.2  4.2 ± 0.7  1.1 ± 0.2   1.9 ± 0.2
 GDX  2.4  ± 0.7^ 1.0  ± 0.4 >   3.5 ± 0.5  0.4 ± 0.1^ 1.3  ± 0.1
 GDX  + T  4.3 ± 0.7  3.2 ± 1.1  5.3 ± 1.6  1.2 ± 0.2   3.9 ± 2.0
24 Months  Intact  2.7 ± 0.9  0.4 ± 0.1  3.1 ± 0.4  0.3 ± 0.1  3.4 ± 1.8
 GDX  2.3  ± 0.9^ 1.4  ± 0.8 >   3.3 ± 0.9  0.3 ± 0.1  3.5 ± 2.1
 GDX  + T  5.1 ± 1.8  5.4 ± 1.5  4.8 ± 1.4   0.4 ± 0.1  1.6 ± 0.3
EXPERIMENT 2
4 Months  Intact  6.6 ± 0.9*  1.8 ± 0.7  3.4 ± 1.6  1.4 ± 0.1  –
 Intact  + T  7 .4 ± 0.1*^ 1.7  ± 0.8  2.5 ± 0.8  3.0 ± 0.8  –
13 Months  Intact  5.4 ± 0.8  3.1 ± 0.2  3.2 ± 1.4  1.5 ± 0.3  –
 Intact  + T  7 .2 ± 0.4*^ 1.3  ± 1.1  0.8 ± 0.0  2.8 ± 0.4  –
24 Months  Intact  2.4 ± 0.6   1.3 ± 0.1  3.2 ± 2.7  0.3 ± 0.1  –
 Intact  + T  7 .6 ± 0.0*^ 3.2  ± 0.2  1.8 ± 1.1  0.4 ± 0.1  –
EXPERIMENT 3
4 Months  Intact  9.0 ± 1.5**  –  3.4 ± 0.4  1.2 ± 0.2## –
 Intact  + 3α-diol 5.4  ± 0.4**  –  3.4 ± 0.3  1.5 ± 0.1^## –
13 Months  Intact  5.2 ± 1.1   –  4.9 ± 2,4  1.1 ± 0.1  –
 Intact  + 3α-diol 8.1  ± 3.2   –  5.2 ± 2.0  1.2 ± 0.1^ –
24 Months  Intact  2.8 ± 0.2  –  2.6 ± 0.0  0.6 ± 0.1  –
 Intact  + 3α-diol 3.4  ± 0.4  –  4.1 ± 0.6  1.3 ± 0.1^ –
*Denotes signiﬁ  cant difference from 13- and 24-month-old rats (p < 0.05). **Denotes signiﬁ  cant difference from 24-month-old rats (p < 0.05). ^Denotes signiﬁ  cant 
difference from intact or intact + vehicle groups (p < 0.05). >Denotes signiﬁ  cant difference from GDX + T  group  (p < 0.05). ##Denotes a trend for difference from 
24-month-old rats (p < 0.05).Frontiers in Aging Neuroscience  www.frontiersin.org  April 2010  | Volume 2  |  Article 15  |  12
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Forced swim task
There was no main effect of age for immobility in the forced 
swim test (Figure 5D), but the pattern of effects suggest that 4- 
and 13-month-old rats spent less time immobile compared to 
24-month-old rats. There was a main effect for androgen status 
[F(1,57) = 27.25,  p <  0.01], such that 3α-diol   administration 
 signiﬁ  cantly decreased immobility compared to vehicle admin-
istration (p < 0.01;  Figure 5D). The signiﬁ  cant  interaction 
between age and hormone condition [F(2,57) = 4.12, p = 0.02], 
was due to the fact that 3α-diol was more effective at decreasing 
immobility in 13- and 24-, rather than 4-, month-old intact rats 
[F(2,57) = 3.22, p = 0.04; Table 2]. There was a main effect of 
androgen condition [F(2,57) = 11.6, p = 0.04], but not age or an 
interaction, for struggling due to 3α-diol administration increas-
ing time struggling compared to vehicle (p = 0.02). There was 
no effect of age or 3α-diol administration, or an interaction, on 
time spent swimming.
Androgen levels (Figure 6, Table 3)
There was a main effect of age, but not 3α-diol administration or 
an interaction, such that 4-month-old rats had increased plasma 
T levels [F(2,30) = 4.05, p = 0.03] compared to 24-month-old rats 
(p = 0.02). 3α-diol administration did not alter plasma or hippoc-
ampal DHT. There were no effects of age, 3α-diol administration, or 
an interaction for plasma DHT levels. A trend towards a main effect 
of age [F(1,30) = 2.95, p = 0.07] was due 4-month-old rats tending 
to have increased plasma 3α-diol levels compared to 24-month-
old rats (p = 0.01). 3α-diol administration signiﬁ  cantly increased 
3α-diol in plasma [F(1,30) = 11.14, p < 0.01] compared to vehicle 
control (p < 0.01). There was a trend for an interaction of age and 
3α-diol condition for plasma [F(2,30) = 2.74, p = 0.07] 3α-diol 
levels, such that levels were increased in 13- and 24-month-old, 
but not 4-month-old, rats.
There was a main effect of age, but not androgen administra-
tion or an interaction, for hippocampal [F(2,30) = 54.8, p < 0.01] T 
levels, such that 4-month-old rats had increased T levels compared 
to 13- (p < 0.01) and 24-month-old (p < 0.01) rats (Figure 6A). 
There was also a main effect of age, but not androgen adminis-
tration or an interaction, on DHT levels, such that 4-month-old 
rats had increased hippocampal [F(2,30) = 54.8, p < 0.01] DHT 
levels compared to 13- (p < 0.01) and 24-month-old (p < 0.01) rats 
(Figure 6B). 3α-diol administration signiﬁ  cantly increased 3α-diol 
in the hippocampus [F(1,30) = 43.7, p < 0.01] compared to vehi-
cle control (p < 0.01; p < 0.01; Figure 6C). There was a signiﬁ  cant 
interaction for hippocampal [F(2,30) = 11.8, p < 0.01] levels, such 
that 3α-diol levels were increased in 13- and 24-month-old, but 
not 4-month-old, rats.
DISCUSSION
Our ﬁ  ndings support the hypothesis that aged rats would have 
decreased plasma and hippocampal androgen levels, and that 
androgen regimen that increased plasma 3α-diol would enhance 
cognitive and affective behavior of rats with decreased steroid 
levels due to GDX or aging. In support, in most experiments, 4-
month-old rats had better performance than aged counterparts 
as evidenced by increased crossover latencies in the inhibitory 
avoidance task, decreased latencies to ﬁ  nd the platform in the water 
maze task, decreased depressive behavior in the forced swim task, 
and decreased freezing in the defensive freezing task. Gonadectomy 
decreased performance in these tasks, with reversals of these effects 
with chronic T replacement, which was most apparent among 
4-, compared to 13- or 24-, month-old rats. Furthermore, acute 
administration of 3α-diol, but not T, improved performance across 
tasks in aged rats. Notably, age decreased 3α-diol in plasma and 
the hippocampus such that 13-month-old rats had signiﬁ  cantly 
greater levels than 24-month-old rats, and 4-month-old rats had 
signiﬁ  cantly greater levels than 13-month-old rats. Additionally, 
T replacement to 4-month-old, but not 13- or 24-month-old, 
GDX rats increased plasma and hippocampal 3α-diol levels. 
These ﬁ  ndings suggest that age-associated deﬁ  cits in cognitive and 
affective performance may be related to 3α-diol metabolism in 
the hippocampus.
The results of the present experiment conﬁ  rm previous reports 
on the effects of aging on behavioral and neuroendocrine proc-
esses of male rats, and the potential role of androgen replacement. 
Aged rats are typically impaired in comparison to younger rats 
on both working and reference memory components of spatial 
tasks, such as the water maze (Barnes, 1979; Gage et al., 1988; 
Gallagher and Burwell, 1989; Ando and Ohashi, 1991; Gallagher 
and Nicolle, 1993; Colombo and Gallagher, 1998). Differences have 
been observed among Fischer 344 rats beginning at middle-age 
Table 5 | 5α-reductase activity of 4-, 13-, and 24-month-old gonadally-
intact (intact), gonadectomized (GDX), or GDX and T-replaced (GDX + T; 
Experiment 1) and intact or intact and T-administered (Experiment 3).
    Conversion ratio in   5α-reductase 
   hippocampus  activity  was
   calculated  with  quantiﬁ  ed by
   radioimmunoassay  thin-layer
 Condition  results  chromatography
Age Steroid    5α-reduction   3α-HSD    5α-reductase
 condition  (DHT  and  3α- (3α-diol   activity (pmol/
    diol to T)  to DHT)  hr/mg protein)
EXPERIMENT 1
4 Months  Intact  2.1 ± 0.5  2.4 ± 0.3  –
 GDX  3.6  ± 1.2  1.0 ± 0.4  –
 GDX  + T   3.1 ± 0.6  3.5 ± 0.3  –
13 Months  Intact  3.9 ± 0.9  3.7 ± 0.8# –
 GDX  2.9  ± 0.5  2.8 ± 0.8# 1.3  ± 0.2
 GDX  + T  2.7 ± 0.7  5.2 ± 0.3# 1.6  ± 0.3
24 Months  Intact  5.1 ± 1.3  2.1 ± 0.5   –
 GDX  3.1  ± 1.1  2.3 ± 0.6   1.7 ± 0
 GDX  + T  1.7 ± 0.6  0.9 ± 0.4   1.5 ± 0.4
EXPERIMENT 2
4 Months  Intact  1.6 ± 0.1  5.0 ± 2.6  0.8 ± 0.1
 Intact  + T   1.2 ± 0.2^ 2.5  ± 1.1  1.1 ± 0.2
13 Months  Intact  4.3 ± 2.9  2.3 ± 0.2  1.3 ± 0.2
 Intact  + T  1.3 ± 0.4^ 2.4  ± 1.1  0.9 ± 0.1
24 Months  Intact   6.8 ± 3.3   1.9 ± 1.3  1.5 ± 0.7
 Intact  + T  0.5 ± 0.4^ 0.4  ± 0.1  1.1 ± 0.2
^Denotes signiﬁ  cant difference from intact + vehicle group (p < 0.05). #Denotes 
trend to be different from 4- and 24-month-old rats (p = 0.5–0.75).Frontiers in Aging Neuroscience  www.frontiersin.org  April 2010  | Volume 2  |  Article 15  |  13
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(i.e. approximately 12–15  months of age; Shukitt-Hale et  al., 
1998) when compared to young adult rats (6 months of age). In 
another strain, Fischer 344 × Brown Norway hybrid, middle-aged 
(13 months old) had similar performance deﬁ  cits in a retention 
trial in the water maze as did 24-month-old rats, compared to 3-
month-old rats (Driscoll et al., 2006). We found that 4-month-old 
rats outperformed their older counterparts in the water maze in 
the present series of experiments. Additionally, similar to what was 
observed in the inhibitory avoidance task in the present study, aged 
(30 months old) male Fischer-344/Brown-Norway had poorer per-
formance than their younger counterparts (3- and 15-month olds) 
for fear conditioning (Kasckow et al., 2005). Fewer studies have 
compared affective behavior of young versus middle-aged versus 
aged male rats. In one study, no differences were observed in the 
forced swim test in aged compared to younger Fischer-344/Brown 
Norway rats (Kasckow et al., 2005). In another study, restraint 
stress decreased anxiety-like responding of middle-aged and aged 
Fischer-344 rats, which were 12- and 24-month-old, respectively, 
compared to 4-month-old rats in the elevated plus maze (Pisarska 
et al., 2000). In the present study, 4-month-old Fischer-344 rats 
demonstrated less anxiety in the defensive freezing task, and more 
depression-like behavior in a one-trial forced swimming task. The 
present study conﬁ  rms previous reports on stress hormone and 
androgen levels with aging in male rats. For instance, similar to 
what was found in Experiment 1 of the present study, in a hybrid 
strain of male Fischer-344/Brown-Norway, no differences were 
observed in basal plasma corticosterone levels when rats were 
assessed during young adulthood (3 months old), middle-age 
(15 months old), and late age (30 months old) (Kasckow et al., 
2005). Androgen levels of male rats begin to decline at middle-
age, at around 13 months old, and salient decreases are noticed 
when rats are around 24 months old (Gray, 1978; Chambers and 
Phoenix, 1984) and we observed similar age-related decline in T 
and 3α-diol levels in the present study. A question is the capac-
ity for rats to respond to androgen-replacement with aging, but 
few studies have examined the effects of androgen-replacement to 
older rats. In one study, T, but not DHT, administration enhanced 
water radial arm maze performance of 23-month-old male rats 
(Bimonte-Nelson et al., 2003). However, in another investigation, T 
did not improve Morris Water maze performance in 31-month-old 
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3α-diol to young, gonadally-intact, or young, GDX rats enhances 
performance in the inhibitory avoidance and water maze tasks, 
similarly decreases anxiety-like behavior in the forced swim and 
defensive freezing tasks.
The present data also support previous studies indicating that 
androgens’ beneﬁ  cial effects on cognitive and affective perform-
ance may be due in part to actions in the hippocampus. Indeed, it 
has been proposed that there is a relationship between impaired 
inhibitory avoidance and water maze performance and induction 
to long-term depression in hippocampal slices (Foster and Kumar, 
2007). Although we did not directly manipulate androgen action in 
the hippocampus in the present study, the present results conﬁ  rm 
ﬁ  ndings of prior studies in young rats that have had androgens’ 
actions manipulated in the hippocampus. In support, androgen 
administration directly to the hippocampus of GDX rats produces 
beneﬁ  cial effects on cognitive and affective behavior similar to that 
found in GDX rats administered systemic androgens (Edinger and 
Frye, 2004, 2005; Edinger et al., 2004). In the present study, behav-
ior in the hippocampally-inﬂ  uenced water maze and inhibitory 
avoidance tasks was enhanced through androgen administration. 
Further, systemic administration of T and/or 3α-diol signiﬁ  cantly 
increased 3α-diol levels in the hippocampus. Notably, only andro-
rats (Goudsmit et al., 1990). One interpretation of these ﬁ  ndings 
and the present results is that T may have limited effects to improve 
performance as rodents age, but the mechanisms for these effects 
require further investigation.
The present results conﬁ  rm previous reports on the effects of 
gonadectomy and androgem administration. The ﬁ  ndings from 
Experiment 1 support previous ﬁ  ndings that GDX can induce 
behavioral deﬁ  cits in measures of cognitive and affective per-
formance (Bing et al., 1998; Ceccareli et al., 2001; Edinger and 
Frye, 2004; Frye et al., 2009). The ﬁ  ndings in Experiments 2 and 
3, that androgen administration to intact rats can enhance cogni-
tive and affective behavior, is also consistent with previous studies 
of   cognitive performance (Ceccareli et al., 2001) and anxiety-like 
behavior (Bitran et al., 1993) illustrating that T administration to 
intact rats enhances these behaviors. The present data also support 
previous studies suggesting that 5α-reduced metabolites are impor-
tant for T’s positive effects on cognitive and affective behavior. 
For example, previous ﬁ  ndings indicate that administration of T 
and its 5α-reduced metabolite, 3α-diol, to young, GDX, rats sig-
niﬁ  cantly enhances cognitive and affective performance (Frye and 
Seliga, 2001; Edinger and Frye, 2004, 2005; Edinger et al., 2004). In 
support, the present ﬁ  ndings indicate that administration of T or 
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gen regimens that increased hippocampal 3α-diol levels were con-
sistently effective at enhancing cognitive and affective behaviors in 
these and the present studies. The present data are also consistent 
with previous experiments in gonadally-intact aged male mice indi-
cating that administration of T or 3α-diol enhances performance 
in the inhibitory avoidance and conditioned contextual fear tasks, 
decreases anxiety behavior in the open ﬁ  eld, light–dark transition, 
mirror maze, and elevated plus maze tasks, and decreases depressive 
behavior in the forced swim task (Frye et al., 2008). Testosterone 
administration did not consistently enhance behavior in the present 
study. However, in this previous study in mice, T administration 
was effective at enhancing cognitive and affective behavior and 
at   elevating hippocampal 3α-diol levels among aged mice. In the 
present study, T administration did not consistently increase hip-
pocampal 3α-diol levels among aged rats. Thus, these differences 
in behavioral outcomes may be due to differences in metabolism. 
It is important to note that the present study looked at the effects 
of peripheral, not central, androgen administration. A question for 
future studies would be the extent to which other brain regions may 
be targets for androgens to inﬂ  uence cognitive and affective behav-
ior and the role of direct manipulation of androgens in the hip-
pocampus, and other brain regions, among aged rodents. Together, 
these data suggest that age-associated deﬁ  cits in performance of 
hippocampally-inﬂ  uenced tasks may be due to actions of T’s 5α-
reduced metabolite, 3α-diol, in the hippocampus.
The present ﬁ  ndings extend previous studies suggesting that 
androgen decline with aging produces cognitive and affective 
deﬁ  cits that can be ameliorated through androgen replacement. 
Investigations of aging in female rodents indicate that aging 
results in deﬁ  cits in cognitive and affective performance that can 
be reduced through administration of T’s aromatized metabolite, 
estrogen (Frick et al., 2002; Markham et al., 2002; Gresack and 
Frick, 2006; Walf et al., 2009; Walf and Frye, 2010), or proges-
terone (Frye and Walf, 2009). Although the effects of androgens 
and aging on   cognitive and affective performance have been less 
thoroughly studied, previous ﬁ  ndings indicate that T and DHT 
to aged female mice can enhance cognitive performance in the 
water maze (Benice and Raber, 2009). Aged, 24-month-old male 
and female mice respond similarly to T, E2, DHT, or 3α-diol to 
produce decreased immobility in the forced swim test (Frye and 
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Walf, 2009). As previously mentioned, systemic administration of 
T or 3α-diol to aged male mice enhances cognitive performance, 
decreases depressive behavior, and decreases anxiety behavior, com-
pared to vehicle administration (Frye et al., 2008). The present study 
extends these ﬁ  ndings to aged male rats and suggests that androgen 
administration can enhance age-associated deﬁ  cits in cognitive and 
affective performance, only when 3α-diol is increased. In support, 
administration of 3α-diol, but not T, consistently enhanced behav-
ior of rats in the water maze, inhibitory avoidance, forced swim, 
and defensive freezing tasks, in the present study. Further, 3α-diol 
was the only androgen that was consistently elevated in the hip-
pocampus at the time of tissue collection among rats that displayed 
enhanced behavior. Given the design of the present experiments 
and that behavioral assessments were done at different points fol-
lowing androgen administration, it was not possible to determine 
whether androgen levels were correlated with behavior. The present 
results support further investigation of this question directly in the 
future. Finally, we had some evidence that 5α-reductase activity 
was altered by age and androgen condition, suggesting that older 
rats may have increased activity and therefore less 3α-diol in the 
hippocampus due to increased back-conversion to T or DHT. Of 
interest is whether aged rats had differences in expression of these 
metabolism enzymes in the hippocampus. In AD patients, steroid 
metabolism enzymes are increased and  positively-related to poorer 
cognitive function (Schaeffer et al., 2006). Notably, aging and/or 
androgen deprivation are associated with increased levels of cho-
lesterol (Spinar et al., 2009; Traish et al., 2009), which may increase 
enzyme activity (Pettersson et al., 2009). Given high variability, 
and low sample size, it would be of interest to more systematically 
examine the activity and expression of these metabolism enzymes, 
and their relation to cholesterol levels, in aged male rats in a future 
study. Together, these data suggest that aging can result in deﬁ  cits in 
cognitive and affective performance that may be due to decreased 
3α-diol levels and/or deﬁ  cits in 5α-reductase metabolism.
The present ﬁ  ndings suggest that androgens’ effects to enhance 
cognitive and affective performance may be due to actions of the 
5α-reduced metabolite, 3α-diol. However, T’s other metabolites 
may also have beneﬁ  cial effects to enhance cognition and affect. 
For example, T can be aromatized to estrogen. In women, estrogen 
levels decline with menopause, which is associated with increased 
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incidence of mood disorders and decreased performance in visuo-
 spatial  tasks  (Miller et al., 2002). In animals, estrogen adminis-
tration increases cognitive performance and decreases anxiety 
behavior of young and aged female rodents (Frick et al., 2002; 
Markham et al., 2002; Gresack and Frick, 2006; Walf et al., 2009; 
Walf and Frye, 2010). Thus, T’s effects to enhance cognitive and 
affective behavior may be due, in part, to estrogen. However, cog-
nitive deﬁ  cits associated with normal aging or AD are associated 
with decreased levels of androgens, but not estrogen (Rosario et al., 
2010). Aromatase knockout mice, which lack the enzyme necessary 
to convert T to estrogen and thus have very low endogenous estro-
gen levels, exhibit normal affective behavior (Dalla et al., 2005). In 
the present study, E2 levels were not consistently elevated in animals 
that showed enhanced behavior in cognitive and affective tasks. 
Only administration of the nonaromatizable metabolite 3α-diol, 
was consistently effective at enhancing behavior across tasks. It is 
also possible that T’s beneﬁ  cial effects are due to actions of DHT. 
Administration of DHT can enhance cognitive and affective behav-
ior of male rodents (Edinger and Frye, 2004; Edinger et al., 2004). 
However, DHT’s effects are inconsistent across tasks. Additionally, 
in the present study, DHT levels were not consistently elevated in 
animals that displayed enhanced behavior. Together, these ﬁ  ndings 
suggest that androgens may have effects to enhance cognitive and 
affective behavior of aged male rats through actions of T’s non-
aromatizable metabolite, 3α-diol.
It is possible that age-related deﬁ  cits in performance may be 
due to differences in stress responses. Older rats have higher and 
longer-lasting stress-induced corticosterone responses than do 
younger rats (Sapolsky et al., 1983), which may inﬂ  uence cogni-
tive performance. Twenty-three- to 28-month-old male rats that 
have impaired performance in the water maze have higher levels 
of corticosterone than do rats of the same age that do not have 
impaired performance, or 6-month-old rats (Lorens et al., 1990). 
Sex differences in stress-induced changes in cognitive performance 
are reduced in aged compared to young adult rats (Hodes and Shors, 
2005). Additionally, mice with the testicular feminization mutation 
(Tfm) that lack functional androgen receptors (ARs) have increased 
plasma corticosterone levels (Zuloaga et al., 2008). However, in 
the present study, basal corticosterone levels were not signiﬁ  cantly 
different as a result of age or hormone condition at the time point 
sampled. Due to limitations in tissues collected, the present study 
was not able to look at corticosterone levels in aged animals that 
were administered 3α-diol in order to determine the impact of 
this metabolite on stress responses. There were no differences in 
ﬂ  inch/jump response to shock in the defensive freezing or inhibi-
tory avoidance tasks, indicating that different ages and/or androgen 
conditions did not experience differences in the perception of this 
task. Another study reported similarities in ﬂ  inch-jump respond-
ing of young and aged Fischer-344 rats (Vasquez et al., 1983). The 
relationship between age-associated deﬁ  cits in performance and 
stress is an area of research that will need to be more thoroughly 
investigated.
The possibility that age-related deﬁ  cits in performance may be 
due to differences in visual and motor performance among aged 
rats needs to be considered. In future studies, a cued trial with a 
visible platform in the Morris Water maze task would allow us 
to make determinations about differences in visual acuity among 
rats across these different age groups, but this potential confound 
could not be addressed in the present study because this type of 
trial was not done. In this task, differences in swim speed due to age 
must also be considered in interpretation of the water maze results. 
Differences in swim speed were only noted during the testing trial 
in Experiment 1 and not during training in any of the Experiments 
or during testing in Experiments 2 and 3. Although we did not see 
clear differences in swim speed across all training or testing trials, 
younger, GDX and T-replaced rats clearly had the fastest swim 
speeds in Experiment 1, which needs to be taken into account in 
light of the fact that this group also have lower latencies to ﬁ  nd 
the platform in this task. These swim speed data do not entirely 
control for age effects in the water maze, but this pattern across 
three experiments suggest that not all effects are due to differences 
in rats’ abilities to swim. Although the results in the water maze 
have these caveats to consider, the present study addresses age and 
androgen-related effects in other tasks to more fully address the 
research question on the role of androgen metabolites in aging 
for functional effects. Indeed, to address other age-related fac-
tors in interpretation of the present results, we have investigated 
whether there were clear differences in training parameters across 
two learning tasks, the inhibitory avoidance and water maze. We 
found that differences in training latencies for the inhibitory avoid-
ance and water maze tasks, and distances swam during training, 
which used various training stimuli, were not consistently different 
across experiments. Additionally, although Experiment 1 showed 
differences in swimming in the forced swim task dependent on age, 
these differences were not consistent across experiments. However, 
it must be noted that results obtained in Experiment 2 must be 
carefully considered because there was a small number of observa-
tions per group. Additionally, no clear and consistent effects of age 
or hormone status for responses to shock stimuli in the inhibitory 
avoidance and defensive freezing tasks, as measured by ﬂ  inch-jump 
ratings, were observed. Further, duration burying in response to 
shock in the defensive freezing task was not different across age 
groups, indicating that age-associated differences in motor behavior 
may have been minimal. Together, these data suggest that not all dif-
ferences in cognitive or affective performance were due to physical 
abilities or sensitivities that may differ with age and/or hormone 
status, but that additional studies that could address these factors 
more systematically would be useful.
There are multiple receptor substrates through which androgens 
may exert their beneﬁ  cial effects. T and DHT bind with high afﬁ  n-
ity to ARs; whereas, 3α-diol has actions at GABAA receptors (GBRs; 
Roselli et al., 1987; Frye et al., 1996a,b) or at estrogen receptor (ER)-β 
in the hippocampus (Kaminski et al., 2005; Pak et al., 2005; Edinger 
and Frye, 2007). Intrahippocampal administration of ﬂ  utamide, an 
AR antagonist, decreases cognitive performance (Edinger and Frye, 
2007) and increases anxiety behavior (Edinger and Frye, 2006) of 
gonadally-intact and DHT-replaced rats. Further, Tfm mice, which 
lack functional ARs, demonstrate increased anxiety in the novel 
object and light/dark transition tasks. However, Tfm mice did not 
consistently show increased anxiety in the open ﬁ  eld or elevated plus 
maze tasks (Zuloaga et al., 2008), indicating that another mechanism 
may be responsible for some of androgens’ beneﬁ  cial effects. A future 
question is the extent to which 3α-diol’s effects in aged rats may be 
due to actions at GABA, ERβ, or other novel steroid targets.Frontiers in Aging Neuroscience  www.frontiersin.org  April 2010  | Volume 2  |  Article 15  |  18
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Androgens’ effects to enhance cognitive and affective perform-
ance in aged rats may take place through their effects to enhance 
neurogenesis. Some anti-depressants exert their beneﬁ  cial effects 
on mood and affect by altering neurogenesis. For example, it has 
been demonstrated that ﬂ  uoxetine can increase neurogenesis in the 
hippocampus (Malberg et al., 2000; Santarelli et al., 2003). There is 
also evidence that androgens can exert neurogenic effects. Male 
voles with high T levels have elevated hippocampal neurogen-
esis compared to voles with low T levels (Spritzer et al., 2004). In 
young rats, administration of T and/or 3α-diol prevents against 
adrenalectomy- or GDX-induced deﬁ  cits in inhibitory avoidance 
performance and neurodegeneration in the granule cell layer of the 
dentate (Frye and McCormick, 2000a,b; Spritzer and Galea, 2007; 
Spritzer et al., 2008) and can increase neurogenesis in the hippoc-
ampus (Kovacs et al., 2003; Leranth et al., 2003, 2004; MacLusky 
et al., 2004, 2006). Among young rats, enhanced neurogenesis is 
  associated with   better   cognitive performance (Shors et al., 2002). 
Aged rodents   demonstrate decreased neurogenesis in the hippoc-
ampus (Kuhn et al., 1996; Erickson and Barnes, 2003), which cor-
responds to deﬁ  cits in conditioned fear testing (Wati et al., 2006). 
Thus, this is an area of research regarding androgens’ effects and 
mechanisms that need to be further investigated.
In summary, the present data demonstrate that aged rodents 
have androgen decline and decrements in cognitive and affective 
performance. Some of these decrements can be improved through 
systemic administration of the non-aromatizable metabolite, 3α-
diol. Additionally, only androgen milieu that were effective at pro-
ducing beneﬁ  cial effects on behavior consistently elevated 3α-diol 
levels in the hippocampus in young and aged rats. Together, these 
ﬁ  ndings suggest that some aging-related decrements in cognitive 
and affective behaviors may be related to decline in production of 
the T metabolite, 3α-diol. Given the aging population, it is particu-
larly important to further investigate the mechanisms and brain 
targets of androgens’ effects in aging individuals.
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